The investigation of efficacy and safety of Ailamide eye drops
- Conditions
- Primary open angle glaucoma Ocular hypertension
- Registration Number
- JPRN-UMIN000040896
- Lead Sponsor
- Department of Ophthalmology, The University of Tokyo
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 101
Not provided
1.Use of other IOP lowering drug or corticosteroid within past 90 days 2.History of surgical treatment for glaucoma 3.History of intraocular surgery within past 90 days 4.Treatment of a triamcinolone acetonide within past 180 days 5.Presence of any active retinal disease which may progress 6.Presence of any active ocular disease other than POAG or ocular hypertension 7.Presence of a serious systemic disease 8.Presence of corneal abnormality which is considered to preclude accurate measurement of IOP by Goldmann applanation tonometer 9.History of corneal transplantation or keratorefractive surgery 10.Decided to be inappropriate for this study by a physician in charge accurate measurement of IOP by Goldmann applanation tonometer 9.History of corneal transplantation or keratorefractive surgery 10.Decided to be inappropriate for this study by a physician in charge
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method IOP change from baseline at 12 weeks of additional administration of Ailamide
- Secondary Outcome Measures
Name Time Method